• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Nationwide Health Properties

Nationwide Health Properties

  1. Innovus Pharma’s Partner Luminarie Receives Approval for Zestra® for Female Sexual Arousal Disorder as a Medical Device I from New Zealand’s Medicines and Medical Devices Safety Authority

    Innovus Pharma’s Partner Luminarie Receives Approval for Zestra® for Female Sexual Arousal Disorder as a Medical Device I from New Zealand’s Medicines and Medical Devices Safety Authority

  2. Innovus Pharma Announces the Launch of Zestra® in France, Belgium and Monaco by Its Partner, Densmore

    Innovus Pharma Announces the Launch of Zestra® in France, Belgium and Monaco by Its Partner, Densmore

  3. Synlogic Presents New Preclinical Data at International Congress of Inborn Errors of Metabolism

    Synlogic Presents New Preclinical Data at International Congress of Inborn Errors of Metabolism

  4. Innovus Pharma Receives Approval from Health Canada for its UriVarx™ Product for the Indication to Reduce Symptoms of Overactive Bladder such as Daytime Urinary Frequency, Urgency and Nocturia

    Innovus Pharma Receives Approval from Health Canada for its UriVarx™ Product for the Indication to Reduce Symptoms of Overactive Bladder such as Daytime Urinary Frequency, Urgency and Nocturia

  5. Innovus Pharma Files Product License Application for the Commercialization of Its Seasonal Allergic Rhinitis Product in Canada

    Innovus Pharma Files Product License Application for the Commercialization of Its Seasonal Allergic Rhinitis Product in Canada

12

©2017 Morningstar Advisor. All right reserved.